Industry: Service & Software
Published Date: 2024-09-04
Pages: 168 Pages
Report ld: 3135379
Request Sample
Customized Report
Microphysiological System Market Size(US$)

CAGR 2024-2030
34.3%
Market Size,2030
USD 867
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
The global market for Microphysiological System was estimated to be worth US$ 113 million in 2023 and is forecast to a readjusted size of US$ 867 million by 2030 with a CAGR of 34.3% during the forecast period 2024-2030.
Global key players of Microphysiological System include Emulate, Mimetas, InSphero, TissUse, CN Bio, etc. The top five players hold a share over 49%. North America is the largest market, with a share about 44%, followed by Europe and Asia-Pacific, with share 42% and 11%, separately. In terms of product type, Human Organ and Tissue Models is the largest segment, occupied for a share of 63%.
The Microphysiological System market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microphysiological System.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Microphysiological System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Microphysiological System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Microphysiological System in country level. It provides sigmate data by Type, and by End User for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Microphysiological System Product Introduction
1.2 Global Microphysiological System Market Size Forecast (2019-2030)
1.3 Microphysiological System Market Trends & Drivers
1.3.1 Microphysiological System Industry Trends
1.3.2 Microphysiological System Market Drivers & Opportunity
1.3.3 Microphysiological System Market Challenges
1.3.4 Microphysiological System Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Microphysiological System Players Revenue Ranking (2023)
2.2 Global Microphysiological System Revenue by Company (2019-2024)
2.3 Key Companies Microphysiological System Manufacturing Base Distribution and Headquarters
2.4 Key Companies Microphysiological System Product Offered
2.5 Key Companies Time to Begin Mass Production of Microphysiological System
2.6 Microphysiological System Market Competitive Analysis
2.6.1 Microphysiological System Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Microphysiological System Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microphysiological System as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Human Organ and Tissue Models
3.1.2 Disease Models
3.1.3 Non-Human Species Models
3.2 Global Microphysiological System Sales Value by Type
3.2.1 Global Microphysiological System Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Microphysiological System Sales Value, by Type (2019-2030)
3.2.3 Global Microphysiological System Sales Value, by Type (%) (2019-2030)
4 Segmentation by End User
4.1 Introduction by End User
4.1.1 Pharmaceutical & Biotechnology Companies
4.1.2 Academic & Research Institutes
4.1.3 Others
4.2 Global Microphysiological System Sales Value by End User
4.2.1 Global Microphysiological System Sales Value by End User (2019 VS 2023 VS 2030)
4.2.2 Global Microphysiological System Sales Value, by End User (2019-2030)
4.2.3 Global Microphysiological System Sales Value, by End User (%) (2019-2030)
5 Segmentation by Region
5.1 Global Microphysiological System Sales Value by Region
5.1.1 Global Microphysiological System Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Microphysiological System Sales Value by Region (2019-2024)
5.1.3 Global Microphysiological System Sales Value by Region (2025-2030)
5.1.4 Global Microphysiological System Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Microphysiological System Sales Value, 2019-2030
5.2.2 North America Microphysiological System Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Microphysiological System Sales Value, 2019-2030
5.3.2 Europe Microphysiological System Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Microphysiological System Sales Value, 2019-2030
5.4.2 Asia Pacific Microphysiological System Sales Value by Region (%), 2023 VS 2030
5.5 South America
5.5.1 South America Microphysiological System Sales Value, 2019-2030
5.5.2 South America Microphysiological System Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Microphysiological System Sales Value, 2019-2030
5.6.2 Middle East & Africa Microphysiological System Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Microphysiological System Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Microphysiological System Sales Value, 2019-2030
6.3 United States
6.3.1 United States Microphysiological System Sales Value, 2019-2030
6.3.2 United States Microphysiological System Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Microphysiological System Sales Value by End User, 2023 VS 2030
6.4 Europe
6.4.1 Europe Microphysiological System Sales Value, 2019-2030
6.4.2 Europe Microphysiological System Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Microphysiological System Sales Value by End User, 2023 VS 2030
6.5 China
6.5.1 China Microphysiological System Sales Value, 2019-2030
6.5.2 China Microphysiological System Sales Value by Type (%), 2023 VS 2030
6.5.3 China Microphysiological System Sales Value by End User, 2023 VS 2030
6.6 Japan
6.6.1 Japan Microphysiological System Sales Value, 2019-2030
6.6.2 Japan Microphysiological System Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Microphysiological System Sales Value by End User, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Microphysiological System Sales Value, 2019-2030
6.7.2 South Korea Microphysiological System Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Microphysiological System Sales Value by End User, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Microphysiological System Sales Value, 2019-2030
6.8.2 Southeast Asia Microphysiological System Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Microphysiological System Sales Value by End User, 2023 VS 2030
6.9 India
6.9.1 India Microphysiological System Sales Value, 2019-2030
6.9.2 India Microphysiological System Sales Value by Type (%), 2023 VS 2030
6.9.3 India Microphysiological System Sales Value by End User, 2023 VS 2030
7 Company Profiles
7.1 Emulate
7.1.1 Emulate Profile
7.1.2 Emulate Main Business
7.1.3 Emulate Microphysiological System Products, Services and Solutions
7.1.4 Emulate Microphysiological System Revenue (US$ Million) & (2019-2024)
7.1.5 Emulate Recent Developments
7.2 Mimetas
7.2.1 Mimetas Profile
7.2.2 Mimetas Main Business
7.2.3 Mimetas Microphysiological System Products, Services and Solutions
7.2.4 Mimetas Microphysiological System Revenue (US$ Million) & (2019-2024)
7.2.5 Mimetas Recent Developments
7.3 InSphero
7.3.1 InSphero Profile
7.3.2 InSphero Main Business
7.3.3 InSphero Microphysiological System Products, Services and Solutions
7.3.4 InSphero Microphysiological System Revenue (US$ Million) & (2019-2024)
7.3.5 InSphero Recent Developments
7.4 TissUse
7.4.1 TissUse Profile
7.4.2 TissUse Main Business
7.4.3 TissUse Microphysiological System Products, Services and Solutions
7.4.4 TissUse Microphysiological System Revenue (US$ Million) & (2019-2024)
7.4.5 TissUse Recent Developments
7.5 CN Bio
7.5.1 CN Bio Profile
7.5.2 CN Bio Main Business
7.5.3 CN Bio Microphysiological System Products, Services and Solutions
7.5.4 CN Bio Microphysiological System Revenue (US$ Million) & (2019-2024)
7.5.5 CN Bio Recent Developments
7.6 Valo Health (TARA Biosystems)
7.6.1 Valo Health (TARA Biosystems) Profile
7.6.2 Valo Health (TARA Biosystems) Main Business
7.6.3 Valo Health (TARA Biosystems) Microphysiological System Products, Services and Solutions
7.6.4 Valo Health (TARA Biosystems) Microphysiological System Revenue (US$ Million) & (2019-2024)
7.6.5 Valo Health (TARA Biosystems) Recent Developments
7.7 Hesperos
7.7.1 Hesperos Profile
7.7.2 Hesperos Main Business
7.7.3 Hesperos Microphysiological System Products, Services and Solutions
7.7.4 Hesperos Microphysiological System Revenue (US$ Million) & (2019-2024)
7.7.5 Hesperos Recent Developments
7.8 TNO
7.8.1 TNO Profile
7.8.2 TNO Main Business
7.8.3 TNO Microphysiological System Products, Services and Solutions
7.8.4 TNO Microphysiological System Revenue (US$ Million) & (2019-2024)
7.8.5 TNO Recent Developments
7.9 AxoSim
7.9.1 AxoSim Profile
7.9.2 AxoSim Main Business
7.9.3 AxoSim Microphysiological System Products, Services and Solutions
7.9.4 AxoSim Microphysiological System Revenue (US$ Million) & (2019-2024)
7.9.5 AxoSim Recent Developments
7.10 Newcells Biotech
7.10.1 Newcells Biotech Profile
7.10.2 Newcells Biotech Main Business
7.10.3 Newcells Biotech Microphysiological System Products, Services and Solutions
7.10.4 Newcells Biotech Microphysiological System Revenue (US$ Million) & (2019-2024)
7.10.5 Newcells Biotech Recent Developments
7.11 Nortis
7.11.1 Nortis Profile
7.11.2 Nortis Main Business
7.11.3 Nortis Microphysiological System Products, Services and Solutions
7.11.4 Nortis Microphysiological System Revenue (US$ Million) & (2019-2024)
7.11.5 Nortis Recent Developments
7.12 Netri
7.12.1 Netri Profile
7.12.2 Netri Main Business
7.12.3 Netri Microphysiological System Products, Services and Solutions
7.12.4 Netri Microphysiological System Revenue (US$ Million) & (2019-2024)
7.12.5 Netri Recent Developments
7.13 Draper Laboratory
7.13.1 Draper Laboratory Profile
7.13.2 Draper Laboratory Main Business
7.13.3 Draper Laboratory Microphysiological System Products, Services and Solutions
7.13.4 Draper Laboratory Microphysiological System Revenue (US$ Million) & (2019-2024)
7.13.5 Draper Laboratory Recent Developments
7.14 Beijing Daxiang Biotech
7.14.1 Beijing Daxiang Biotech Profile
7.14.2 Beijing Daxiang Biotech Main Business
7.14.3 Beijing Daxiang Biotech Microphysiological System Products, Services and Solutions
7.14.4 Beijing Daxiang Biotech Microphysiological System Revenue (US$ Million) & (2019-2024)
7.14.5 Beijing Daxiang Biotech Recent Developments
7.15 Altis Biosystems
7.15.1 Altis Biosystems Profile
7.15.2 Altis Biosystems Main Business
7.15.3 Altis Biosystems Microphysiological System Products, Services and Solutions
7.15.4 Altis Biosystems Microphysiological System Revenue (US$ Million) & (2019-2024)
7.15.5 Altis Biosystems Recent Developments
7.16 Cherry Biotech
7.16.1 Cherry Biotech Profile
7.16.2 Cherry Biotech Main Business
7.16.3 Cherry Biotech Microphysiological System Products, Services and Solutions
7.16.4 Cherry Biotech Microphysiological System Revenue (US$ Million) & (2019-2024)
7.16.5 Cherry Biotech Recent Developments
7.17 Bi/ond
7.17.1 Bi/ond Profile
7.17.2 Bi/ond Main Business
7.17.3 Bi/ond Microphysiological System Products, Services and Solutions
7.17.4 Bi/ond Microphysiological System Revenue (US$ Million) & (2019-2024)
7.17.5 Bi/ond Recent Developments
7.18 Obatala Sciences
7.18.1 Obatala Sciences Profile
7.18.2 Obatala Sciences Main Business
7.18.3 Obatala Sciences Microphysiological System Products, Services and Solutions
7.18.4 Obatala Sciences Microphysiological System Revenue (US$ Million) & (2019-2024)
7.18.5 Obatala Sciences Recent Developments
7.19 Ananda Devices
7.19.1 Ananda Devices Profile
7.19.2 Ananda Devices Main Business
7.19.3 Ananda Devices Microphysiological System Products, Services and Solutions
7.19.4 Ananda Devices Microphysiological System Revenue (US$ Million) & (2019-2024)
7.19.5 Ananda Devices Recent Developments
7.20 ImmuONE
7.20.1 ImmuONE Profile
7.20.2 ImmuONE Main Business
7.20.3 ImmuONE Microphysiological System Products, Services and Solutions
7.20.4 ImmuONE Microphysiological System Revenue (US$ Million) & (2019-2024)
7.20.5 ImmuONE Recent Developments
7.21 React4life
7.21.1 React4life Profile
7.21.2 React4life Main Business
7.21.3 React4life Microphysiological System Products, Services and Solutions
7.21.4 React4life Microphysiological System Revenue (US$ Million) & (2019-2024)
7.21.5 React4life Recent Developments
7.22 AlveoliX
7.22.1 AlveoliX Profile
7.22.2 AlveoliX Main Business
7.22.3 AlveoliX Microphysiological System Products, Services and Solutions
7.22.4 AlveoliX Microphysiological System Revenue (US$ Million) & (2019-2024)
7.22.5 AlveoliX Recent Developments
7.23 BiomimX
7.23.1 BiomimX Profile
7.23.2 BiomimX Main Business
7.23.3 BiomimX Microphysiological System Products, Services and Solutions
7.23.4 BiomimX Microphysiological System Revenue (US$ Million) & (2019-2024)
7.23.5 BiomimX Recent Developments
7.24 Aracari Bio
7.24.1 Aracari Bio Profile
7.24.2 Aracari Bio Main Business
7.24.3 Aracari Bio Microphysiological System Products, Services and Solutions
7.24.4 Aracari Bio Microphysiological System Revenue (US$ Million) & (2019-2024)
7.24.5 Aracari Bio Recent Developments
7.25 StemPharm
7.25.1 StemPharm Profile
7.25.2 StemPharm Main Business
7.25.3 StemPharm Microphysiological System Products, Services and Solutions
7.25.4 StemPharm Microphysiological System Revenue (US$ Million) & (2019-2024)
7.25.5 StemPharm Recent Developments
7.26 SynVivo
7.26.1 SynVivo Profile
7.26.2 SynVivo Main Business
7.26.3 SynVivo Microphysiological System Products, Services and Solutions
7.26.4 SynVivo Microphysiological System Revenue (US$ Million) & (2019-2024)
7.26.5 SynVivo Recent Developments
8 Industry Chain Analysis
8.1 Microphysiological System Industrial Chain
8.2 Microphysiological System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Microphysiological System Sales Model
8.5.2 Sales Channel
8.5.3 Microphysiological System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Microphysiological System market is projected to grow from US$ 250 million in 2025 to US$ 719 million by 2032, at a CAGR of 16.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-15
Pages: 183
USD 4900.00
(Single User License)
The global Microphysiological System market size was US$ 250 million in 2025 and is forecast to reach a readjusted size of US$ 719 million by 2032 with a CAGR of 16.2% during the forecast period 2026-2032.
Published Date: 2026-08-15
Pages: 164
USD 4250.00
(Single User License)
The global Microphysiological System market was valued at US$ 250 million in 2025 and is anticipated to reach US$ 719 million by 2032, at a CAGR of 16.2% from 2026 to 2032.
Published Date: 2026-08-15
Pages: 163
USD 2900.00
(Single User License)
The global market for Microphysiological System was estimated to be worth US$ 250 million in 2025 and is projected to reach US$ 719 million, growing at a CAGR of 16.2% from 2026 to 2032.
Published Date: 2026-08-15
Pages: 175
USD 3950.00
(Single User License)
The global market for Microphysiological System was estimated to be worth US$ 148 million in 2024 and is forecast to a readjusted size of US$ 1134 million by 2031 with a CAGR of 34.3% during the forecast period 2025-2031.
Published Date: 2025-10-14
Pages: 222
USD 3950.00
(Single User License)
The global market for Microphysiological System was estimated to be worth US$ 126 million in 2024 and is forecast to a readjusted size of US$ 370 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published Date: 2025-10-13
Pages: 180
USD 3950.00
(Single User License)
The global Microphysiological System market size was US$ 126 million in 2024 and is forecast to a readjusted size of US$ 370 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published Date: 2025-10-13
Pages: 121
USD 4250.00
(Single User License)
The global Microphysiological System market is projected to grow from US$ 126 million in 2024 to US$ 370 million by 2031, at a CAGR of 16.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-13
Pages: 177
USD 4900.00
(Single User License)
The global market for Microphysiological System was valued at US$ 126 million in the year 2024 and is projected to reach a revised size of US$ 370 million by 2031, growing at a CAGR of 16.2% during the forecast period.
Published Date: 2025-10-13
Pages: 119
USD 2900.00
(Single User License)
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
Published Date: 2024-09-04
Pages: 165
USD 4350.00
(Single User License)
The global Microphysiological System market is projected to grow from US$ 250 million in 2025 to US$ 719 million by 2032, at a CAGR of 16.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-15
Pages: 183
The global Microphysiological System market size was US$ 250 million in 2025 and is forecast to reach a readjusted size of US$ 719 million by 2032 with a CAGR of 16.2% during the forecast period 2026-2032.
Published: 2026-08-15
Pages: 164
The global Microphysiological System market was valued at US$ 250 million in 2025 and is anticipated to reach US$ 719 million by 2032, at a CAGR of 16.2% from 2026 to 2032.
Published: 2026-08-15
Pages: 163
The global market for Microphysiological System was estimated to be worth US$ 250 million in 2025 and is projected to reach US$ 719 million, growing at a CAGR of 16.2% from 2026 to 2032.
Published: 2026-08-15
Pages: 175
The global market for Microphysiological System was estimated to be worth US$ 148 million in 2024 and is forecast to a readjusted size of US$ 1134 million by 2031 with a CAGR of 34.3% during the forecast period 2025-2031.
Published: 2025-10-14
Pages: 222
The global market for Microphysiological System was estimated to be worth US$ 126 million in 2024 and is forecast to a readjusted size of US$ 370 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published: 2025-10-13
Pages: 180
The global Microphysiological System market size was US$ 126 million in 2024 and is forecast to a readjusted size of US$ 370 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.
Published: 2025-10-13
Pages: 121
The global Microphysiological System market is projected to grow from US$ 126 million in 2024 to US$ 370 million by 2031, at a CAGR of 16.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-13
Pages: 177
The global market for Microphysiological System was valued at US$ 126 million in the year 2024 and is projected to reach a revised size of US$ 370 million by 2031, growing at a CAGR of 16.2% during the forecast period.
Published: 2025-10-13
Pages: 119
Microphysiological Systems (MPS) are in vitro models composed of cells, tissue explants, or stem-cell derived 'organoid' formations of human or animal origin. These models provide translational biochemical, electrical, and/or physiomechanical responses to represent organ and tissue function, with great potential to replace some animals used in research. According to the U.S. Food and Drug Administration (FDA), MPS model "functional features of a specific tissue or organ of human or animal origin by exposing cells to a microenvironment that mimics the physiological aspects important for their function or pathophysiological condition." These systems are being developed to better mimic some aspects of specific organ systems or combinations of organ systems to improve upon standard two-dimensional (2D) cell systems, with the goal of eventually replacing animal models being used for hazard identification, risk assessment, and disease modeling, among other uses.
Published: 2024-09-04
Pages: 165
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now